Every scored company in Pharma, sorted by Combined Score by default. Comparing companies within the same sector is generally more meaningful than across unrelated industries, since valuation norms and typical debt levels differ enough between sectors that a raw PE or ROE can look misleading without that context.
Average combined score of the companies in Pharma, month by month. Sep 2026: 50.8 (±0.0 vs Aug 2026)
A change of less than 2 points counts as "about the same". Uses today's list of companies in Pharma for every month, so the line compares like with like.